Brantford, Canada

Mandy Dorsey

This inventor holds 1 USPTO granted patent. Top assignee: Affinium Pharmaceuticals, Inc.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mandy Dorsey. Retrieved from https://idiyas.com/inventor/mandy-dorsey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mandy Dorsey: Innovator in Drug Target Research

Introduction

Mandy Dorsey is a notable inventor based in Brantford, Canada. She has made significant contributions to the field of drug development, particularly in identifying novel drug targets for pathogenic bacteria. Her work is crucial in the ongoing battle against bacterial infections.

Latest Patents

Mandy Dorsey holds 1 patent related to her innovative research. The patent focuses on purified proteins derived from a specific amino acid sequence, which are essential for developing new therapeutic strategies against pathogenic bacteria. This invention provides valuable biochemical and biophysical characteristics of the polypeptides involved.

Career Highlights

Mandy is currently associated with Affinium Pharmaceuticals, Inc., where she continues to advance her research in drug development. Her expertise and dedication to her work have positioned her as a key player in her field.

Collaborations

Mandy collaborates with talented professionals, including Judd Berman and Molly B. Schmid. These partnerships enhance her research efforts and contribute to the success of her projects.

Conclusion

Mandy Dorsey is a pioneering inventor whose work in drug target research is making a significant impact in the medical field. Her innovative approach and collaboration with other experts are paving the way for future advancements in combating bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…